デフォルト表紙
市場調査レポート
商品コード
1435374

酵素の世界市場レポート 2024

Enzymes Global Market Report 2024

出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 250 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.16円
酵素の世界市場レポート 2024
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 250 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 目次
概要

酵素の市場規模は、今後数年間で急速に成長すると予想されています。 2028年には14.0%の年間複合成長率(CAGR)で228億6,000万米ドルに成長すると予想されます。予測される成長は、市場の需要の変化、持続可能な実践への焦点、健康動向、バイオ燃料/再生可能エネルギー、および新たなアプリケーションによって推進されます。主な動向としては、バイオテクノロジーの進歩、持続可能性の重視、食品・飲料業界の需要の増加、産業用途の拡大、天然物に対する消費者の嗜好などが挙げられます。

酵素市場は、消化器疾患の有病率の増加により成長すると予想されています。消化器系に影響を与えるこれらの疾患には、胃食道逆流症(GERD)、がん、過敏性腸症候群(IBS)、乳糖不耐症、食道裂孔ヘルニア、胆石などの症状が含まれます。消化の酵素は、食物を吸収可能な分子に分解する上で重要な役割を果たします。 2022年 10月の時点で、米国国立バイオテクノロジー情報センター(NCBI)は、米国における過敏性腸症候群(IBS)の有病率は10%~15%であり、患者のほぼ12%がIBS関連の治療を求めていると報告しています。プライマリケアの実践における懸念。この消化器疾患の増加は酵素市場の成長に貢献しています。

酵素市場はがんの罹患率の増加によって加速すると予想されており、化学療法には薬物代謝酵素(DME)の使用が必要となっています。これらの酵素は体内で活性化して、がん細胞を破壊し、腫瘍を破壊します。がん患者の腫瘍組織および代謝器官における薬物代謝酵素(DME)の発現と機能は、抗がん剤や化学療法に対する反応が低い患者にとって極めて重要です。米国がん協会による「Cancer Facts and Figures 2022」報告書では、2022年の米国における新たながん症例数は推定190万人とされており、これは2020年に報告された180万人からの増加を反映しています。一方、2022年のがんによる死亡者数の推定数はこれをわずかに上回っています。 2021年の608,570人と比較して、609,360人の死亡が予測されています。治療用 酵素で治療可能ながんの有病率の上昇により、酵素市場の成長が促進されると予想されます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年~2023年
  • 世界の市場規模予測と成長、2023年~2028年、2033年

第6章 市場セグメンテーション

  • 世界の酵素市場、製品タイプ別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
  • アスパラギナーゼ
  • リパーゼ
  • プロテアーゼ
  • ナットウキナーゼ
  • キチナーゼ
  • セラチペプチダーゼ
  • コラゲナーゼ
  • リガーゼ
  • その他の製品
  • 世界の酵素市場、用途別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
  • 白血病
  • 胃の病気
  • 抗腫瘍
  • 皮膚潰瘍
  • ゴーシェ病
  • ファブリー病
  • その他の用途
  • 世界の酵素市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
  • 製薬会社
  • 病院
  • プライベートクリニック
  • 研究

第7章 地域および国の分析

  • 世界の酵素市場、地域別、実績および予測、2018-2023、2023-2028年、2033年
  • 世界の酵素市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 酵素市場の競合情勢
  • 酵素市場の企業プロファイル
    • BASF SE
    • Hoffmann-La Roche AG
    • Merck Sharp &Dohme LLC
    • Sanofi SA
    • Thermo Fisher Scientific Inc.

第31章 その他の大手および革新的な企業

  • Associated British Foods plc
  • DuPont de Nemours Inc.
  • Kerry Group plc
  • Firmenich SA
  • Koninklijke DSM NV
  • Dyadic International Inc.
  • Novozymes A/S
  • Endo International plc
  • Chr Hansen Holding A/S
  • Advanced Enzyme Technologies Ltd.
  • Catalyst Pharmaceuticals Inc.
  • Codexis Inc.
  • AB Enzymes GmbH
  • Brain Biotech AG
  • Biocatalysts Ltd.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

目次
Product Code: r15092

Enzymes are proteins that commonly function as biological catalysts, accelerating specific chemical reactions within cells without undergoing any alterations themselves.

Various enzyme product types include asparaginase, lipase, protease, nattokinase, chitinase, serratiopeptidase, collagenase, ligase, and others. Protease, for instance, catalyzes proteolysis, breaking down proteins into smaller polypeptides or individual amino acids while facilitating the creation of new protein products. These enzymes find application in treating conditions such as leukemia, stomach disorders, antitumor therapies, skin ulcers, Gaucher disease, Fabry disease, among others. They are utilized by drug manufacturers, hospitals, private clinics, and research laboratories.

The enzymes market research report is one of a series of new reports from The Business Research Company that provides enzymes market statistics, including enzymes industry global market size, regional shares, competitors with an enzymes market share, detailed enzymes market segments, market trends, and opportunities, and any further data you may need to thrive in the enzymes industry. This enzymes market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The enzymes market size has grown rapidly in recent years. It will grow from $11.78 billion in 2023 to $13.52 billion in 2024 at a compound annual growth rate (CAGR) of 14.8%. The growth observed in the historical period can be attributed to several factors, including globalization fostering market expansion, increased investments in research and development, growing consumer awareness and demand, advancements in bioprocessing technology, and a focus on waste reduction and recycling initiatives.

The enzymes market size is expected to see rapid growth in the next few years. It will grow to $22.86 billion in 2028 at a compound annual growth rate (CAGR) of 14.0%. Forecasted growth is driven by market demand shifts, sustainable practices focus, health trends, biofuel/renewable energy, and emerging applications. Major trends include biotech advancements, sustainability emphasis, increased demand in food/beverage industries, industrial application expansion, and consumer preference for natural products.

The enzyme market is anticipated to experience growth driven by an increase in the prevalence of digestive disorders. These disorders, impacting the digestive system, encompass conditions such as gastroesophageal reflux disease (GERD), cancer, irritable bowel syndrome (IBS), lactose intolerance, hiatal hernia, and gallstones. Digestive enzymes play a crucial role in breaking down food into absorbable molecules. As of October 2022, the National Center for Biotechnology Information (NCBI) reports that the prevalence of irritable bowel syndrome (IBS) in the United States ranges between 10% and 15%, with nearly 12% of patients seeking medical care for IBS-related concerns in primary care practices. This rise in digestive disorders contributes to the growth of the enzyme market.

The enzyme market is expected to be fueled by the increasing prevalence of cancer, necessitating the use of drug-metabolizing enzymes (DMEs) for chemotherapy. These enzymes activate within the body to destroy cancer cells and break down tumors. The expression and functionality of drug-metabolizing enzymes (DMEs) in the tumor tissues and metabolic organs of cancer patients are crucial for those with a low response to anticancer drugs and chemotherapy. The Cancer Facts and Figures 2022 report by the American Cancer Society indicates an estimated 1.9 million new cancer cases in the United States in 2022, reflecting an increase from the 1.8 million reported in 2020. While the estimated number of cancer deaths in 2022 is slightly higher than in 2021, with 609,360 projected deaths compared to 608,570 in 2021. The rising prevalence of cancer treatable with therapeutic enzymes is anticipated to propel the growth of the enzyme market.

Leading companies in the enzyme market are focusing on innovation by developing advanced products such as Lamzede, catering to the needs of patients. Lamzede (velmanase alfa) is a pharmaceutical product designed for the treatment of alpha-mannosidosis, a rare genetic disorder characterized by insufficient activity of the lysosomal alpha-galactosidase-A enzyme. In a noteworthy development in May 2023, Chiesi Global Rare Diseases, a pharmaceutical manufacturing company based in the United States, obtained FDA approval for Lamzede (velmanase alfa). This approval pertains to the treatment of non-neurological symptoms in patients with mild-to-moderate alpha-mannosidosis. Lamzede represents a recombinant form of human alpha-mannosidase, developed using recombinant DNA technology in mammalian Chinese hamster ovary (CHO) cells. It stands out as the first enzyme replacement therapy sanctioned in the U.S. for addressing the non-central nervous system manifestations of alpha-mannosidosis.

A notable trend gaining prominence in the enzymes market is the exploration of novel approaches for cancer treatment utilizing enzymes. Substantial investments in research by major universities and companies aim to advance enzyme therapies for combating cancer. In another significant development in May 2023, Chiesi Global Rare Diseases secured FDA approval for ELFABRIO (pegunigalsidase alfa-iwxj), designed to address Fabry disease. This rare genetic disorder is characterized by insufficient activity of the lysosomal a-galactosidase-A enzyme, leading to the progressive accumulation of globotriaosylceramide (Gb3) in blood vessel walls throughout the body. ELFABRIO (pegunigalsidase alfa-iwxj) stands out as a PEGylated enzyme replacement therapy (ERT).

In February 2023, AstraZeneca, a U.S.-based pharmaceutical company, completed the acquisition of CinCor Pharma Inc. for $1.3 billion. This strategic move is set to strengthen AstraZeneca's cardiorenal pipeline through the incorporation of CinCor's candidate drug, baxdrostat (CIN-107). Baxdrostat is an aldosterone synthase inhibitor (ASI) designed for lowering blood pressure in individuals with treatment-resistant hypertension. CinCor Pharma Inc., the acquired biotechnology company, is based in the United States and is focused on the development of enzyme-based therapeutics.

Major companies operating in the enzymes market report are Ramboll Group A/S, Jacobs Engineering Group Inc., AECOM Technical Services Inc., ERM Group Limited, WSP Global Inc., SNC-Lavalin Group Inc., Wood PLC, Stantec Inc., Black & Veatch Corporation, Tetra Tech Inc., Arcadis NV, Mott MacDonald Group Ltd., GHD Group Limited, TRC Companies Inc., Form Technologies Inc., Golder Associates Ltd., Cardno Limited, CH2M HILL Engineers Inc., SLR Consulting Ltd., Weston Solutions Inc., IndustrySafe Inc., ECS Limited, Geosyntec Consultants LLC, Apex Companies Inc., GZA GeoEnvironmental Technologies Inc., Haley & Aldrich Inc., Intelex Corporation, iAuditor Inc., Metrix Software Solutions Inc., Lighthouse Systems Inc., SafetyTek Inc., Strategix Application Solutions LLC, Effivity Technologies LLC, SiteDocs Inc., SafetySync LLC, Qooling Systems Inc.

North America was the largest region in the enzymes market in 2023. The regions covered in the enzymes market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the enzymes market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The enzyme market consists of sales of oxidoreductases, transferases, and hydrolases. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Enzymes Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on enzymes market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for enzymes ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The enzymes market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Product Type: Asparaginase; Lipase; Protease; Nattokinase; Chitinase; Serratiopeptidase; Collagenase; Ligase; Other Products
  • 2) By Application: Leukemia; Stomach Disorders; Antitumor; Skin Ulcers; Gaucher Disease; Fabry Disease; Other Applications
  • 3) By End User: Drug Manufacturers; Hospitals; Private Clinics; Research Laboratories
  • Companies Mentioned: Ramboll Group A/S; Jacobs Engineering Group Inc.; AECOM Technical Services Inc.; ERM Group Limited; WSP Global Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Enzymes Market Characteristics

3. Enzymes Market Trends And Strategies

4. Enzymes Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Enzymes Market Size and Growth

  • 5.1. Global Enzymes Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Enzymes Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Enzymes Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Enzymes Market Segmentation

  • 6.1. Global Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Asparaginase
  • Lipase
  • Protease
  • Nattokinase
  • Chitinase
  • Serratiopeptidase
  • Collagenase
  • Ligase
  • Other Products
  • 6.2. Global Enzymes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Leukemia
  • Stomach Disorders
  • Antitumor
  • Skin Ulcers
  • Gaucher Disease
  • Fabry Disease
  • Other Applications
  • 6.3. Global Enzymes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Drug Manufacturers
  • Hospitals
  • Private Clinics
  • Research Laboratories

7. Enzymes Market Regional And Country Analysis

  • 7.1. Global Enzymes Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Enzymes Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Enzymes Market

  • 8.1. Asia-Pacific Enzymes Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Enzymes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Enzymes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Enzymes Market

  • 9.1. China Enzymes Market Overview
  • 9.2. China Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Enzymes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Enzymes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Enzymes Market

  • 10.1. India Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Enzymes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Enzymes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Enzymes Market

  • 11.1. Japan Enzymes Market Overview
  • 11.2. Japan Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Enzymes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Enzymes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Enzymes Market

  • 12.1. Australia Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Enzymes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Enzymes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Enzymes Market

  • 13.1. Indonesia Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Enzymes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Enzymes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Enzymes Market

  • 14.1. South Korea Enzymes Market Overview
  • 14.2. South Korea Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Enzymes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Enzymes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Enzymes Market

  • 15.1. Western Europe Enzymes Market Overview
  • 15.2. Western Europe Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Enzymes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Enzymes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Enzymes Market

  • 16.1. UK Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Enzymes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Enzymes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Enzymes Market

  • 17.1. Germany Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Enzymes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Enzymes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Enzymes Market

  • 18.1. France Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Enzymes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Enzymes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Enzymes Market

  • 19.1. Italy Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Enzymes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Enzymes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Enzymes Market

  • 20.1. Spain Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Enzymes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Enzymes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Enzymes Market

  • 21.1. Eastern Europe Enzymes Market Overview
  • 21.2. Eastern Europe Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Enzymes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Enzymes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Enzymes Market

  • 22.1. Russia Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Enzymes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Enzymes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Enzymes Market

  • 23.1. North America Enzymes Market Overview
  • 23.2. North America Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Enzymes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Enzymes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Enzymes Market

  • 24.1. USA Enzymes Market Overview
  • 24.2. USA Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Enzymes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Enzymes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Enzymes Market

  • 25.1. Canada Enzymes Market Overview
  • 25.2. Canada Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Enzymes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Enzymes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Enzymes Market

  • 26.1. South America Enzymes Market Overview
  • 26.2. South America Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Enzymes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Enzymes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Enzymes Market

  • 27.1. Brazil Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Enzymes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Enzymes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Enzymes Market

  • 28.1. Middle East Enzymes Market Overview
  • 28.2. Middle East Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Enzymes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Enzymes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Enzymes Market

  • 29.1. Africa Enzymes Market Overview
  • 29.2. Africa Enzymes Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Enzymes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Enzymes Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Enzymes Market Competitive Landscape And Company Profiles

  • 30.1. Enzymes Market Competitive Landscape
  • 30.2. Enzymes Market Company Profiles
    • 30.2.1. BASF SE
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Hoffmann-La Roche AG
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Merck Sharp & Dohme LLC
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Sanofi SA
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Thermo Fisher Scientific Inc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Enzymes Market Other Major And Innovative Companies

  • 31.1. Associated British Foods plc
  • 31.2. DuPont de Nemours Inc.
  • 31.3. Kerry Group plc
  • 31.4. Firmenich SA
  • 31.5. Koninklijke DSM NV
  • 31.6. Dyadic International Inc.
  • 31.7. Novozymes A/S
  • 31.8. Endo International plc
  • 31.9. Chr Hansen Holding A/S
  • 31.10. Advanced Enzyme Technologies Ltd.
  • 31.11. Catalyst Pharmaceuticals Inc.
  • 31.12. Codexis Inc.
  • 31.13. AB Enzymes GmbH
  • 31.14. Brain Biotech AG
  • 31.15. Biocatalysts Ltd.

32. Global Enzymes Market Competitive Benchmarking

33. Global Enzymes Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Enzymes Market

35. Enzymes Market Future Outlook and Potential Analysis

  • 35.1 Enzymes Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Enzymes Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Enzymes Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer